Status:
UNKNOWN
Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases
Lead Sponsor:
ADIR Association
Conditions:
Interstitial Lung Disease
Pulmonary Rehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
in this study, the investigators aim to describe the effects of highflow nasal canulae oxygen therapy (HFNC) on respiratory muscle function during exercise in patients with fibrosing interstitial lung...
Eligibility Criteria
Inclusion
- Cared for as part of a respiratory rehabilitation program (ADIR association)
- Presenting diffuse fibrosing interstitial pneumonitis, documented by CT scan data and whatever its etiology
- Presenting severe hypoxemia in ambient air (SpO2\<90%) during an exercise test (6-minute walk test or functional exercise test)
Exclusion
- Patient with a contraindication to carrying out a respiratory rehabilitation program
- Patient having presented an exacerbation of PID, pneumothorax or pneumomediastinum in the 3 months preceding potential inclusion
- Tracheostomized patient
- Patient with a contraindication to the placement of a nasogastric tube
- Pregnant or breastfeeding women or women of childbearing age without effective means of contraception (a pregnancy test will be carried out)
- Protected adult patient (guardianship or curatorship)
- Patient deprived of liberty by court or administrative decision
- Refusal of patient participation or consent
Key Trial Info
Start Date :
November 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 23 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05372926
Start Date
November 22 2022
End Date
November 23 2024
Last Update
November 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ADIR association
Bois-Guillaume, France, 76230